Buscar
-
Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes.
(Cardiovascular Diabetology. vol. 21, n° 1, pp. 206, 2022-10-11)Article de revueLibre acceso -
Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms.
(Cardiovascular Diabetology. vol. 21, n° 1, pp. 242, 2022-11-15)Article de revueLibre acceso -
Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure.
(Journal of Clinical Medicine. vol. 11, n° 6, 2022-03-11)Article de revueLibre acceso -
Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population.
(Cardiovascular Diabetology. vol. 21, n° 1, pp. 247, 2022-11-17)Article de revueLibre acceso -
Astrocytic junctional adhesion molecule-A regulates T-cell entry past the glia limitans to promote central nervous system autoimmune attack.
(Brain Communications. vol. 4, n° 2, pp. fcac044, 2022-01-01)Article de revueLibre acceso -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre acceso -
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
(Blood Cancer Journal. vol. 12, n° 4, pp. 56, 2022-04-08)Article de revueLibre acceso -
Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression.
(Molecular and Cellular Biochemistry, 2022-03-25)Article de revueLibre acceso -
Decrease of Pdzrn3 is required for heart maturation and protects against heart failure.
(Scientific Reports. vol. 12, n° 1, pp. 8, 2022-01-07)Article de revueLibre acceso -
Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.
(Journal of the American Medical Association. vol. 327, n° 5, pp. 442-453, 2022-02-01)Article de revueLibre acceso